tiprankstipranks
Trending News
More News >
CareDx Inc (CDNA)
:CDNA
US Market
Advertisement

CareDx (CDNA) Earnings Dates, Call Summary & Reports

Compare
824 Followers

Earnings Data

Report Date
Mar 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.01
Last Year’s EPS
1.51
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter with significant revenue growth and operational improvements, including successful product launches and strategic initiatives. However, the overall market conditions for transplant volumes have been flat, and the expected impact from the IOTA program has not yet been realized.
Company Guidance
During the CareDx Third Quarter 2025 Financial Results Conference Call, the company provided updated guidance reflecting strong performance. Total revenue for the third quarter reached $100.1 million, marking a 21% year-over-year increase, with Testing Services revenue at $72.2 million and delivering approximately 50,300 tests. CareDx raised its full-year 2025 revenue guidance to a range of $372 million to $376 million and adjusted EBITDA guidance to $35 million to $39 million, highlighting significant operational improvements. The company also reported a 13% year-over-year increase in test volume and a 5% increase in revenue per test, driven by enhanced revenue cycle management. Additionally, CareDx emphasized its focus on innovation and customer engagement, with new product launches such as HistoMap Kidney and strategic appointments to strengthen its leadership team.
Strong Revenue Growth
Total revenue of $100.1 million grew 21% year-over-year, with all three business segments generating record quarterly revenue.
Improved EBITDA and Share Repurchase
Adjusted EBITDA was $15.3 million, more than double Q3 last year. The company repurchased an additional 2 million shares during the quarter.
Launch of HistoMap Kidney
CareDx launched HistoMap Kidney, a breakthrough tissue-based molecular test, at the American Society of Nephrology meeting.
Revenue Cycle Management Success
The company achieved over 200% improvement in total appeals volume and a 60% improvement in claims submission time, with cash collections accelerating to 124% of testing services revenue.
EPIC Integration Enhancements
EPIC Aura integration projects are in process, with positive feedback from the Boston Children's pilot, leading to a 20% reduction in order turnaround time.

CareDx (CDNA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CDNA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 2026
2025 (Q4)
-0.01 / -
1.51
Nov 04, 2025
2025 (Q3)
-0.08 / 0.03
-0.14121.43% (+0.17)
Aug 06, 2025
2025 (Q2)
-0.10 / -0.16
-0.03-433.33% (-0.13)
Apr 30, 2025
2025 (Q1)
-0.21 / -0.19
-0.3240.63% (+0.13)
Feb 26, 2025
2024 (Q4)
-0.41 / 1.51
-2.21168.33% (+3.72)
Nov 04, 2024
2024 (Q3)
-0.25 / -0.14
-0.4367.44% (+0.29)
Jul 31, 2024
2024 (Q2)
-0.40 / -0.03
-0.4693.48% (+0.43)
May 09, 2024
2024 (Q1)
-0.47 / -0.32
-0.4427.27% (+0.12)
Feb 28, 2024
2023 (Q4)
-0.45 / -2.21
-0.34-550.00% (-1.87)
Nov 08, 2023
2023 (Q3)
-0.59 / -0.43
-0.32-34.37% (-0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CDNA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$14.52$16.53+13.84%
Aug 06, 2025
$13.10$12.07-7.86%
Apr 30, 2025
$16.88$15.07-10.72%
Feb 26, 2025
$21.10$21.06-0.19%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does CareDx Inc (CDNA) report earnings?
CareDx Inc (CDNA) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
    What is CareDx Inc (CDNA) earnings time?
    CareDx Inc (CDNA) earnings time is at Mar 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CDNA EPS forecast?
          CDNA EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.

            CareDx (CDNA) Earnings News

            CareDx Plummets on Disappointing Q1 Showing
            Premium
            Market News
            CareDx Plummets on Disappointing Q1 Showing
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis